Vor Bio to Participate in the Oppenheimer's 35th Annual Healthcare Life Sciences Conference
03 2월 2025 - 10:00PM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in a fireside
chat and host virtual 1x1 investor meetings at the Oppenheimer’s
35th Annual Healthcare Life Sciences Conference.
Oppenheimer’s 35th
Annual Healthcare Life Sciences ConferenceFireside
Chat: Wednesday, February 12th at 12:00pm ET Location: Virtual
A live webcast and archived replay of the fireside chat will be
available on the investors section of www.vorbio.com.
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Vor Biopharma (NASDAQ:VOR)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025
